Eli Lilly is just weeks away from launching ... which was approved by the MHRA last year, the Mounjaro KwikPen can be used to treat adults with type 2 diabetes and for weight management in adult ...

The good news for India is that Eli Lilly plans to introduce tirzepatide for Type 2 diabetes and weight loss ... branded as KwikPen, with dosages between 2.5 mg and 15 mg. Tirzepatide had received ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

And that's before we get into the company's pipeline, which features plenty of investigational drugs beyond Eli Lilly's core area of diabetes and obesity. Even with Eli Lilly's Mounjaro and ...

For patients looking for a sustainable weight-loss treatment, the service's clinicians can prescribe a Mounjaro KwikPen, a new once-weekly injectable medication that can help you lose weight.

Eli Lilly's sales growth is coming short of expectations, which is a problem considering its valuation. The company does have a vast lineup and a deep pipeline that go beyond diabetes and obesity.

Minnesota Attorney General Keith Ellison announced on Monday that a settlement has been reached Novo Nordisk over the high ...

Keith Ellison said he's reached a deal with Danish pharmaceutical company Novo Nordisk to keep the cost of insulin at $35 a ...